NexImmune, a start-up company formed in part by US-based Johns Hopkins University School of Medicine faculty members, has hired both a executive president and a chairman of its clinical and scientific advisory board as part of a technology transfer license for developing immunity against diseases and cancers.

Kenneth Carter has joined NexImmune as its executive president and Jonathan Schneck has become chairman of the company’s Clinical and Scientific Advisory Board.

Previously, Carter was also chief executive for 10 years…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?